BRPI0910345A2 - análogos de oxitocina - Google Patents

análogos de oxitocina

Info

Publication number: BRPI0910345A2
Authority: BR; Brazil
Prior art keywords: oxytocin analogs; oxytocin; analogs
Prior art date: 2008-03-31

Application number

BRPI0910345A

Other languages

English (en)

Inventor

Claudio Schteingart

Kazimierz Wisniewski

Robert Galyean

Sudar Algarsamy

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-31

Filing date

2009-03-30

Publication date

2015-10-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722695&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0910345(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-03-30 Application filed by Ferring Bv filed Critical Ferring Bv

2015-10-06 Publication of BRPI0910345A2 publication Critical patent/BRPI0910345A2/pt

2021-08-17 Publication of BRPI0910345B1 publication Critical patent/BRPI0910345B1/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pregnancy & Childbirth (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

BRPI0910345-7A 2008-03-31 2009-03-30 Compostos análogos de oxitocina, composição farmacêutica compreendendo os mesmos e uso dos ditos análogos BRPI0910345B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4097308P	2008-03-31	2008-03-31
US61/040,973		2008-03-31
EP08251739		2008-05-19
EP08251739.2		2008-05-19
PCT/IB2009/005351 WO2009122285A1 (en)	2008-03-31	2009-03-30	Oxitocin analogues

Publications (2)

Publication Number	Publication Date
BRPI0910345A2 true BRPI0910345A2 (pt)	2015-10-06
BRPI0910345B1 BRPI0910345B1 (pt)	2021-08-17

Family

ID=39722695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0910345-7A BRPI0910345B1 (pt)	2008-03-31	2009-03-30	Compostos análogos de oxitocina, composição farmacêutica compreendendo os mesmos e uso dos ditos análogos

Country Status (21)

Country	Link
US (1)	US8673841B2 (pt)
EP (2)	EP2626364A1 (pt)
JP (1)	JP5539310B2 (pt)
KR (1)	KR101558404B1 (pt)
CN (1)	CN101983205B (pt)
AU (1)	AU2009233429B2 (pt)
BR (1)	BRPI0910345B1 (pt)
CA (1)	CA2718148C (pt)
DK (1)	DK2260053T3 (pt)
ES (1)	ES2488992T3 (pt)
HK (1)	HK1146064A1 (pt)
HR (1)	HRP20140716T1 (pt)
IL (1)	IL208039A (pt)
MX (1)	MX2010010743A (pt)
NZ (1)	NZ587817A (pt)
PL (1)	PL2260053T3 (pt)
PT (1)	PT2260053E (pt)
RU (1)	RU2496788C2 (pt)
SI (1)	SI2260053T1 (pt)
WO (1)	WO2009122285A1 (pt)
ZA (1)	ZA201006733B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2575853B1 (en)	2010-05-25	2016-08-24	INSERM - Institut National de la Santé et de la Recherche Médicale	Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
JO3400B1 (ar) *	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
JP6067878B2 (ja)	2012-12-21	2017-01-25	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	オキシトシンアゴニストとしてのペプチド
CN106414479B (zh) *	2014-06-03	2021-08-03	豪夫迈·罗氏有限公司	作为催产素激动剂的肽
CR20160562A (es) *	2014-06-06	2017-01-06	Hoffmann La Roche	Péptidos como agonistas de la oxitocina
US10588980B2 (en)	2014-06-23	2020-03-17	Novartis Ag	Fatty acids and their use in conjugation to biomolecules
HRP20240166T1 (hr)	2014-09-19	2024-04-26	Ferring B.V.	Postupak liječenja prader-willijevog sindroma
CN106084015B (zh) *	2016-08-25	2020-01-31	成都圣诺生物制药有限公司	一种合成卡贝缩宫素的方法
US20190135859A1 (en)	2017-08-11	2019-05-09	Ferring B.V.	Method of manufacturing a pharmaceutical composition
AU2018312956B2 (en)	2017-08-11	2022-03-10	Ferring B.V.	Method of manufacturing a pharmaceutical composition
CN107628975B (zh) *	2017-09-17	2019-10-29	贵州医科大学	赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用
TW202031283A (zh)	2018-09-20	2020-09-01	馬克Ｃ曼寧	穩定卡貝縮宮素鼻內製劑
EP3852724A4 (en)	2018-09-20	2022-07-06	Levo Therapeutics, Inc.	CARBETOCIN DRUG PRODUCT AND PROCESS FOR ITS MANUFACTURE
JP7390031B2 (ja)	2018-12-27	2023-12-01	国立大学法人金沢大学	オキシトシン誘導体及びその使用
JP2023500763A (ja)	2019-11-04	2023-01-11	フェリングベスローテンフェンノートシャップ	泌乳の改善のためのメロトシンの鼻腔内投与
WO2022026463A1 (en) *	2020-07-27	2022-02-03	Arizona Board Of Regents On Behalf Of The University Of Arizona	Oxytocin analogues and methods for using the same
KR20240007126A (ko)	2021-03-26	2024-01-16	오티4비	연하곤란의 치료
WO2024044633A2 (en) *	2022-08-23	2024-02-29	Seattle Children's Hospital (D/B/A Seattle Children's Research Institute)	Oxytocin derivatives and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604341D0 (sv) *	1996-11-26	1996-11-26	Ferring Bv	Hepta-peptide oxytocin analogue
DE60309847T2 (de)	2002-02-27	2007-10-18	Ferring B.V.	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga

2009
- 2009-03-30 MX MX2010010743A patent/MX2010010743A/es active IP Right Grant
- 2009-03-30 ES ES09727031.8T patent/ES2488992T3/es active Active
- 2009-03-30 BR BRPI0910345-7A patent/BRPI0910345B1/pt active IP Right Grant
- 2009-03-30 KR KR1020107024207A patent/KR101558404B1/ko active IP Right Grant
- 2009-03-30 AU AU2009233429A patent/AU2009233429B2/en active Active
- 2009-03-30 EP EP13156710.9A patent/EP2626364A1/en not_active Withdrawn
- 2009-03-30 NZ NZ587817A patent/NZ587817A/en unknown
- 2009-03-30 JP JP2011502454A patent/JP5539310B2/ja active Active
- 2009-03-30 CN CN200980111919.5A patent/CN101983205B/zh active Active
- 2009-03-30 PT PT97270318T patent/PT2260053E/pt unknown
- 2009-03-30 SI SI200930966T patent/SI2260053T1/sl unknown
- 2009-03-30 PL PL09727031T patent/PL2260053T3/pl unknown
- 2009-03-30 DK DK09727031.8T patent/DK2260053T3/da active
- 2009-03-30 CA CA2718148A patent/CA2718148C/en active Active
- 2009-03-30 RU RU2010139634/04A patent/RU2496788C2/ru active
- 2009-03-30 US US12/933,858 patent/US8673841B2/en active Active
- 2009-03-30 EP EP09727031.8A patent/EP2260053B1/en active Active
- 2009-03-30 WO PCT/IB2009/005351 patent/WO2009122285A1/en active Application Filing
2010
- 2010-09-07 IL IL208039A patent/IL208039A/en active IP Right Grant
- 2010-09-20 ZA ZA2010/06733A patent/ZA201006733B/en unknown
- 2010-12-31 HK HK10112315.1A patent/HK1146064A1/xx unknown
2014
- 2014-07-25 HR HRP20140716AT patent/HRP20140716T1/hr unknown

Also Published As

Publication number	Publication date
WO2009122285A1 (en)	2009-10-08
MX2010010743A (es)	2010-11-04
JP5539310B2 (ja)	2014-07-02
JP2011516460A (ja)	2011-05-26
IL208039A (en)	2016-03-31
KR101558404B1 (ko)	2015-10-08
EP2626364A1 (en)	2013-08-14
DK2260053T3 (da)	2014-06-23
CN101983205B (zh)	2015-08-19
ZA201006733B (en)	2011-06-29
AU2009233429B2 (en)	2014-02-13
CA2718148A1 (en)	2009-10-08
NZ587817A (en)	2012-05-25
US8673841B2 (en)	2014-03-18
BRPI0910345B1 (pt)	2021-08-17
PT2260053E (pt)	2014-08-29
US20110044905A1 (en)	2011-02-24
RU2496788C2 (ru)	2013-10-27
CN101983205A (zh)	2011-03-02
HRP20140716T1 (hr)	2014-08-29
WO2009122285A8 (en)	2009-12-10
ES2488992T3 (es)	2014-09-01
IL208039A0 (en)	2010-12-30
SI2260053T1 (sl)	2014-08-29
AU2009233429A1 (en)	2009-10-08
KR20110005705A (ko)	2011-01-18
EP2260053A1 (en)	2010-12-15
HK1146064A1 (en)	2011-05-13
PL2260053T3 (pl)	2014-11-28
RU2010139634A (ru)	2012-05-10
EP2260053B1 (en)	2014-05-14
CA2718148C (en)	2017-11-07

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-16	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2019-12-03	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-18	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-12-08	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-03-23	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-06-29	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-08-17	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

Publication	Publication Date	Title
CY2017026I1 (el)	2017-11-14	Τετρακυκλικη ενωση
BRPI0910345A2 (pt)	2015-10-06	análogos de oxitocina
SMT201600351B (it)	2016-11-10	Composti antivirali
SMT201600008B (it)	2016-02-25	Composti di piridazinone
BR112012006859A2 (pt)	2019-09-24	compostos
DK2427449T3 (da)	2013-04-22	Vinylindazolylforbindelser
BRPI0911269A2 (pt)	2015-09-29	análogos de halicondrina b
BRPI1013614A2 (pt)	2019-09-24	compostos substituídos de espiro-amida
BRPI0823379A2 (pt)	2015-07-14	Análogos de glucagon
BRPI0823377A2 (pt)	2016-09-27	análogos de glucagon
BRPI0823376A2 (pt)	2015-06-16	Análagos de glucagon
BRPI0823378A2 (pt)	2019-09-24	análogos de glucagon
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
BRPI0912271A2 (pt)	2015-10-20	co-autoria estruturada
BRPI1005525A2 (pt)	2016-02-23	compostos de azaazuleno
BRPI1008774A2 (pt)	2016-03-08	espiroamida substituída
BRPI1013868A2 (pt)	2016-04-05	composto diaciletilenodiamina
DK2323972T3 (da)	2013-10-07	C7-fluor-substituerede tetracylinforbindelser
DK2297162T3 (da)	2012-11-26	Forbindelser
UY33156A (es)	2011-07-29	Nuevos compuestos tienopirrol
BRPI0915562A2 (pt)	2016-01-26	tamis melhorado
BRPI0915442A2 (pt)	2017-06-27	tamis melhorado
BRPI0916432A2 (pt)	2016-02-16	compostos